Arbor Biotechnologies Company

Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
Technology: Biopharma, Biotechnology, Life Science
Industry: Early Drug Development
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2016-01-01
Employees Number: 51-100
Funding Status: Early Stage Venture
Investors Number: 21
Total Funding: 230600000
Estimated Revenue: Less than $1M
Last Funding Date: 2021-11-09
Last Funding Type: Series B

Visit Website
press@arbor.bio
Register and Claim Ownership